Result Presentation for September 30, 2016
Jyothy Laboratories Ltd has informed BSE about : 1. Result Presentation for the period ended September 30, 201625-10-2016
25-10-2016
Allotment of Equity Shares under Jyothy Laboratories Employees Stock Options Scheme 2014 (ESOS 2014)
Jyothy Laboratories Ltd has informed BSE that the ESOP Allotment Committee of Board of Directors of the Company at its meeting held on October 25, 2016 has issued and allotted 35,266 (Thirty Five Thousand Two Hundred Sixty Six) Equity Shares of face value of Re.1/- each of the Company under Jyothy Laboratories Employees Stock Options Scheme 2014 (ESOS 2014) to the eligible employees of the Company.25-10-2016
Outcome of Board Meeting
Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 25, 2016 at 11.30 a.m. and concluded at 1.30 p.m inter alia, have :1. Approved re-appointment of Mr. K. Ullas Kamath designated as Joint Managing Director & Chief Financial Officer for a period of 5 years, subject to approval of the Shareholders of the Company;...25-10-2016
Standalone & Consolidated Financial Results, Limited Review Report, Results Press Release for September 30, 2016
Jyothy Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Result Press Release for the period ended September 30, 201625-10-2016
Change in Credit Rating
Jyothy Laboratories Ltd has informed BSE that Credit Rating In respect of 4000 Zero Coupon, Secured, Redeemable Non convertible Debentures of Rs. 10,00,000 each aggregating to Rs. 400 Crores bearing ISIN - INE668F07038 has been revised from CARE AA - [Double A Minus] to CARE AA [Double A].24-10-2016
Updates on Board Meeting on Oct 25, 2016
With reference to the earlier letter dated October 17, 2016 regarding Board Meeting on October 25, 2016, Jyothy Laboratories Ltd has further informed BSE that consent of shareholders of the Company for issue of new non-convertible debt securities, if approved by the Board of Directors at its meeting scheduled to be held on October 25, 2016, will be sought by way of postal ballot.18-10-2016
Intimation of Schedule of Earnings Call for Analyst(s)
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Schedule of Earnings Call for Analyst(s)".18-10-2016
Board Meeting on October 25, 2016
Jyothy Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on October 25, 2016, inter-alia, to consider and approve Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2016 subject to Limited Review by the Statutory Auditors of the Company....17-10-2016
Shareholding for the Period Ended September 30, 2016
Jyothy Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here15-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Jyothy Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-10-2016